This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2025 Zacks Investment Research | 101 N Wacker Drive, Floor 15, Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +23.75% per year. These returns cover a period from January 1, 1988 through July 7, 2025. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
View All Zacks #1 Ranked Stocks
Zacks News
Monster Beverage's (MNST) Growth Strategies Good: Apt to Hold
by Zacks Equity Research
Monster Beverage (MNST) gains from strength in its energy drinks category and product innovations.
Kimberly-Clark (KMB) Tops Q1 Earnings Estimates, Ups FY24 View
by Zacks Equity Research
Kimberly-Clark's (KMB) first-quarter 2024 results reflect higher earnings on increased operating profit. Taking into account a solid start to fiscal 2024, management raised its annual guidance.
McCormick (MKC) Benefits From Strategic Buyouts & Cost Savings
by Zacks Equity Research
McCormick's (MKC) commitment to achieving long-term objectives is evident from its proven track record, wide-reaching and competitive global portfolio and focus on high-growth areas.
UTZ or CELH: Which Is the Better Value Stock Right Now?
by Zacks Equity Research
UTZ vs. CELH: Which Stock Is the Better Value Option?
Kraft Heinz (KHC) on Track With Pricing Actions Amid Inflation
by Zacks Equity Research
Robust pricing strategies have been protecting Kraft Heinz's (KHC) margin performance amid inflation. The focus on three key pillars is noteworthy.
General Mills (GIS) Gains From Accelerate Strategy, Solid Brands
by Zacks Equity Research
General Mills (GIS) benefits from its Accelerate strategy. Brand strength and pricing actions aid growth amid cost inflation.
Service Corporation (SCI) Gains From Cemetery Unit & Expansion
by Zacks Equity Research
Service Corporation (SCI) benefits from its growth strategies and Cemetery unit strength amid soft Funeral segment revenues.
Post Holdings (POST) Gains on Favorable Pricing & Brand Strength
by Zacks Equity Research
Post Holdings (POST) has been benefiting from strategic pricing actions undertaken to counter inflationary headwinds. Management is strengthening its business on the back of strategic acquisitions.
Medifast's (MED) Transformation on Track Amid Macro Headwinds
by Zacks Equity Research
Medifast (MED) adapts to shifting consumer behavior to maintain its relevance. However, it is facing difficulties in attracting customers due to the rapidly changing economy and inflation.
United Natural's (UNFI) Transformation on Track Amid Challenges
by Zacks Equity Research
United Natural (UNFI) is on track with its transformation goals and is poised to realize the value of its platform fully. However, management is operating in a volatile environment, with consumers buying.
Flowers Foods (FLO) Down More Than 15% in a Year: Here's Why
by Zacks Equity Research
Flowers Foods (FLO) is troubled by a volatile consumer landscape and cost woes. The sales view for 2024 considers slight volume degradation from continuing category declines and selected business exits.
Lamb Weston (LW) Down More Than 25% in 3 Months: Here's Why
by Zacks Equity Research
Lamb Weston (LW) is grappling with higher cost inflation for key inputs. Soft restaurant traffic trends pose a threat to its volumes.
Here's Why Church & Dwight (CHD) Appears to be a Promising Pick
by Zacks Equity Research
Church & Dwight (CHD) benefits from brand strength, efficient pricing and productivity gains. Favorable demand has been an upside.
Hormel Foods (HRL) Looks Appetizing on Foodservice Demand
by Zacks Equity Research
Hormel Foods' (HRL) long-standing relationships, differentiated product portfolio, innovative solutions and impressive sales team are fueling growth in the Foodservice business.
Constellation Brands (STZ) Beats on Q4 Earnings, Sales Rise
by Zacks Equity Research
Constellation Brands (STZ) posts solid sales in fourth-quarter fiscal 2024, backed by strength in the beer business and momentum in the Modelo brand family.
J&J Snack (JJSF) Bolsters Portfolio With Thinsters Acquisition
by Zacks Equity Research
J&J Snack Foods (JJSF) acquires Thinsters, enhancing its snack portfolio with the addition of the brand known for its thin, quality cookies, aligning with the trend toward healthier snack options.
Altria's (MO) Smoke-Free Strength Helps Navigate Challenges
by Zacks Equity Research
Altria (MO) benefits from its focus on smoke-free product expansion and pricing power amid low cigarette volumes.
Philip Morris (PM) Smoke-Free Options Aid Amid Volume Concerns
by Zacks Equity Research
Philip Morris (PM) benefits from its focus on a smoke-free transition and strategic priorities amid soft cigarette volumes and cost concerns.
Pilgrim's Pride (PPC) Stock Gains 50% in a Year: Here's Why
by Zacks Equity Research
Pilgrim's Pride's (PPC) strong operational growth in Mexico, Europe, and the United States through brand innovation and strategic investments leads to significant market success and profitability.
Hershey (HSY) Benefits From Effective Pricing & Buyouts
by Zacks Equity Research
Hershey (HSY) undertakes buyouts to augment portfolio strength and boost revenues. The company's strategic pricing initiatives are yielding.
Here's Why Clorox's (CLX) Strategic Efforts Appear Good
by Zacks Equity Research
Clorox (CLX) benefits from robust pricing and cost-saving initiatives. The company's IGNITE strategy also bodes well.
Here's Why Mondelez (MDLZ) Appears to be a Delectable Pick
by Zacks Equity Research
Mondelez (MDLZ) undertakes regular innovation and efforts to reshape its portfolio to focus on growth areas. Also, the company benefits from effective pricing.
COTY Benefits From Core Priorities & Strategic Partnerships
by Zacks Equity Research
Coty (COTY) is benefiting from its focus on six strategic pillars that are aimed at sustainable growth. Management made several partnerships to enhance its brand portfolio.
Here's Why Newell's (NWL) Strategic Efforts Appear Encouraging
by Zacks Equity Research
Newell's (NWL) strategic endeavors, including enhancing digital business and cost-saving efforts, bode well.
Sysco (SYY) Benefits From Recipe for Growth Amid Cost Woes
by Zacks Equity Research
Sysco (SYY) is focused on its Recipe for Growth plans. The company is on track with prudent buyouts to grow its distribution network and customer base.